Home About Nobel Crisis
Free Book Blog WikiVirus Contact

The Center for the Biology of Chronic Disease

Gene-Eden-VIR is Antiviral: Results of a Post marketing clinical study


According to the study: "... the clinical study showed that Gene-Eden-VIR is a safe and effective treatment against the Human Papillomavirus (HPV), Herpes Simplex Virus (HSV), Epstein Barr Virus (EBV), Human Cytomegalovirus (HCMV), and Hepatitis C Virus (HCV). Therefore, health care practitioners should recommend Gene-Eden-VIR as a safe and effective antiviral treatment against these viruses."


The study was conducted by Hanan Polansky and Edan Itzkovitz from the Center for the Biology of Chronic Disease. The study was published in the reputable, peer reviewed, medical journal Pharmacology and Pharmacy, in the special edition Advances in Antiviral Drugs.

There are two products on the market, Novirin and Gene-Eden-VIR, that have the same five natural ingredients: 100 mg of quercetin, 150 mg of green tea extract, 50 mg of a cinnamon extract, 25 mg of a licorice extract, and 100 mcg of selenium. The difference between the two products is that Novirin has higher quality, more expensive ingredients.

Click Novirin or Gene-Eden-VIR to read more information about these products.

Following publication of the study, many doctors started prescribing Gene-Eden-VIR to their patients. See, for instance, the following four prescriptions for Gene-Eden-VIR (some information was blacked out to protect the privacy of the people involved).

    

    




 


Find us on Google+

2014 CBCD All rights reserved